These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33958853)

  • 21. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure.
    Shrestha K; Shao Z; Singh D; Dupont M; Tang WH
    Am J Cardiol; 2012 Nov; 110(9):1329-35. PubMed ID: 22835414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after kidney surgery.
    Sprenkle PC; Wren J; Maschino AC; Feifer A; Power N; Ghoneim T; Sternberg I; Fleisher M; Russo P
    J Urol; 2013 Jul; 190(1):159-64. PubMed ID: 23391468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of renal tubular damage in chronic heart failure.
    Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
    Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
    Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
    Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors.
    Latoch E; Konończuk K; Taranta-Janusz K; Muszyńska-Rosłan K; Szymczak E; Wasilewska A; Krawczuk-Rybak M
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):741-749. PubMed ID: 33052454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine NGAL and KIM-1 in children and adolescents with hyperuricemia.
    Tomczak J; Wasilewska A; Milewski R
    Pediatr Nephrol; 2013 Sep; 28(9):1863-9. PubMed ID: 23673972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia.
    Güneş A; Ece A; Aktar F; Tan İ; Söker M; Karabel D; Balık H; Uluca Ü; Şen V; Yolbaş İ
    Med Sci Monit; 2015 Dec; 21():4023-9. PubMed ID: 26697893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can Urinary KIM-1 and NGAL Predict Management Endoscopic Surgery in Acute Unilateral Obstructive Stone Disease? Results from a Prospective Cohort Study.
    Göger YE; Özkent MS; Topçu C; Atıcı A; Sönmez MG; Balasar M; Gürbilek M
    Urol Int; 2022; 106(5):446-454. PubMed ID: 34333489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study.
    Jacobson MH; Wu Y; Liu M; Attina TM; Naidu M; Karthikraj R; Kannan K; Warady BA; Furth S; Vento S; Trachtman H; Trasande L
    PLoS Med; 2020 Oct; 17(10):e1003384. PubMed ID: 33052911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Renal Function Status in Steady-State Sickle Cell Anaemic Children Using Urine Human Neutrophil Gelatinase-Associated Lipocalin and Albumin:Creatinine Ratio.
    Olawale OO; Adekanmbi AF; Sonuga AA; Sonuga OO; Akodu SO; Ogundeyi MM
    Med Princ Pract; 2021; 30(6):557-562. PubMed ID: 34348300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary calprotectin, NGAL, and KIM-1 in the differentiation of primarily inflammatory vs. non-inflammatory stable chronic kidney diseases.
    Seibert FS; Sitz M; Passfall J; Haesner M; Laschinski P; Buhl M; Bauer F; Rohn B; Babel N; Westhoff TH
    Ren Fail; 2021 Dec; 43(1):417-424. PubMed ID: 33663323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Foster MC; Coresh J; Bonventre JV; Sabbisetti VS; Waikar SS; Mifflin TE; Nelson RG; Grams M; Feldman HI; Vasan RS; Kimmel PL; Hsu CY; Liu KD;
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):1956-63. PubMed ID: 26350438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of kidney injury in preeclampsia: Increased maternal and urinary levels of NGAL and KIM-1 and their enhanced expression in proximal tubule epithelial cells.
    Wang Y; Gu Y; Gu X; Cooper DB; Lewis DF
    Front Med (Lausanne); 2023; 10():1130112. PubMed ID: 37089603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary NGAL for the diagnosis of the renal injury from multiple myeloma.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M
    Cancer Biomark; 2017; 18(1):41-46. PubMed ID: 27814274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of renal function in obese and overweight children with NGAL and KIM-1 biomarkers.
    Gul A; Yilmaz R; Ozmen ZC; Gumuser R; Demir O; Unsal V
    Nutr Hosp; 2020 Jul; 34(3):436-442. PubMed ID: 32207310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary kidney injury molecules in children with febrile seizures.
    Güneş A; Ece A; Akça H; Aktar F; Mete Ş; Samanci S; Uluca Ü; Şen V; Tan İ; Kaplan İ
    Ren Fail; 2016 Oct; 38(9):1377-1382. PubMed ID: 27557879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NAG: potential cardiorenal biomarker indicates the progression of chronic kidney disease in implantable cardioverter defibrillator patients, contrary to KIM-1.
    Allgaier R; Strack C; Wallner S; Hubauer U; Uecer E; Lehn P; Keyser A; Luchner A; Maier L; Jungbauer C
    Biomark Med; 2022 Mar; 16(4):265-275. PubMed ID: 35176879
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary tubular protein-based biomarkers in the rodent model of cisplatin nephrotoxicity: a comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney injury.
    Sinha V; Vence LM; Salahudeen AK
    J Investig Med; 2013 Mar; 61(3):564-8. PubMed ID: 23360846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.